Skip to main content
LFVN
NASDAQ Life Sciences

LifeVantage Swings to $196K Q1 Loss as Revenue Falls 22% to $37.1M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$5.01
Mkt Cap
$66.598M
52W Low
$3.9
52W High
$11.71
52W Position info
28% above low
Off High info
57% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LFVN sits 28% above its 52-week low of $3.9.

Summary

LifeVantage's fiscal Q1 revenue fell 22% to $37.1M and the company swung to a $196K net loss as gross margin compressed on inventory write-downs and active accounts fell 19%.


Key Events · Earnings and Guidance · LFVN

  • Q1 Revenue Falls 22% to $37.1M

    Net revenue was $37.1M versus $47.6M a year earlier, driven by a $4.4M drop in MindBody GLP-1 System sales, a $4.1M decline in Protandim and $2.3M lower TrueScience, partly offset by $1.7M from the acquired LoveBiome line.

  • Swing to $196K Net Loss

    Net loss was $196K, or $(0.02) per diluted share, versus net income of $2.155M, or $0.17, a year ago; operating result was a $136K loss against $2.268M of income.

  • Gross Margin Drops to 75.4%

    Cost of sales rose as a share of revenue to 24.6% from 20.5%, mainly on $1.3M of inventory obsolescence charges, of which $1.0M related to the MindBody GLP-1 System, plus higher shipping and warehouse costs.

  • Active Accounts Down 19%

    Total Active Accounts fell to 98,000 from 121,000 and Active Customers to 58,000 from 73,000; Americas accounts dropped 20.9% and Asia/Pacific & Europe 13.3%.


Analysis · LFVN · Life Sciences

The top line was already out this morning, but the 10-Q shows the damage reached the bottom line: revenue fell 22% to $37.1M and the company posted a $196K net loss versus $2.155M of profit a year ago. Gross margin dropped to 75.4% from 79.5%, with $1.3M of inventory obsolescence charges (including $1.0M on the MindBody GLP-1 System) doing most of the damage. Demand is the underlying problem: Active Accounts are down 19.0% to 98,000 and Active Customers down 20.5% to 58,000, so the erosion is in the sales force, not just one product. Cash slipped to $13.7M from $14.9M, but operating cash flow turned positive at $0.5M and the $5.0M revolver is undrawn, so there is no near-term liquidity crisis. The board also moved the fiscal year-end to December 31, which will make the next reported period a six-month transition stub.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LFVN was trading at $5.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $66.6M. The 52-week trading range was $3.90 to $11.71. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LFVN - Latest Insights

LFVN
Nov 09, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.01
Real-time Price: $4.95 info
Change: -$0.060 (-1%) info
Market Cap: $66.598M info
LFVN
Aug 27, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.45
Real-time Price: $4.95 info
Change: -$1.50 (-23%) info
Market Cap: $66.598M info
LFVN
Aug 27, 2026, 4:05 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $6.45
Real-time Price: $4.95 info
Change: -$1.50 (-23%) info
Market Cap: $66.598M info
LFVN
Aug 27, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.45
Real-time Price: $4.95 info
Change: -$1.50 (-23%) info
Market Cap: $66.598M info
LFVN
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $4.95 info
Change: +$0.050 (+1%) info
Market Cap: $66.598M info